PDF herunterladen
Synthesis 2001(12): 1778-1779
DOI: 10.1055/s-2001-17519
SHORTPAPER
© Georg Thieme Verlag Stuttgart · New York

Synthesis of Rofecoxib, (MK 0966, Vioxx ® 4-(4′-Methylsulfonylphenyl)-3-Phenyl-2(5H)-Furanone), a Selective and Orally Active Inhibitor of Cyclooxygenase-2

Michel Thérien*, Jacques Yves Gauthier, Yves Leblanc, Serge Léger, Hélène Perrier, Petpiboon Prasit, Zhaoyin Wang
Merck Frosst Centre for Therapeutic Research, P.O. Box 1005, Pointe Claire - Dorval, Québec, Canada H9R 4P8
Fax: +1(514)4284939; e-Mail: Michel_Therien@Merck.com;
Weitere Informationen

Publikationsverlauf

Received 26 January 2001
Publikationsdatum:
12. August 2004 (online)

    Lizenzen und Reprints Alle Artikel dieser Rubrik

Abstract

The synthesis of Vioxx® (Rofecoxib, MK 966, 4-(4’methylsulfonylphenyl)-3-phenyl-2(5H)-furanone), a newly FDA approved inhibitor of cyclooxygenase-2, is described.

Keywords

lactones - sulfones - anti-inflammatory drugs

    References

  • 1a Kargmann S. Wong E. Greig GM. Falgueyret JP. Cromlish W. Ethier D. Yergey JA. Riendeau D. Evans JF. Kennedy B. Tagari P. Francis D. O’Neill GP. Biochem. Pharmacol.  1996,  52:  1113 
    CrossrefGoogle Scholar
  • 1b Brideau C. Kargman S. Liu S. Dallob AL. Ehrich EW. Rodger IW. Chan C.-C. Inflamm. Res.  1996,  45:  68 
    CrossrefGoogle Scholar
  • 2a Chan C.-C. Boyce S. Brideau C. Charleson C. Cromlish W. Ethier D. Evans JF. Ford-Hutchinson AW. Forrest MJ. Gauthier JY. Gordon R. Gresser M. Guay J. Kargmann S. Kennedy B. Leblanc Y. Léger S. Mancini J. O’Neill GP. Ouellet M. Patrick D. Percival MD. Perrier H. Prasit P. Rodger IW. Tagari P. Thérien M. Vickers P. Visco D. Wang Z. Webb J. Wong E. Xu L.-J.. Young RN. Zamboni R. Riendeau D. J. Pharmacol. Exp. Ther.  1999,  290:  551 
    CrossrefGoogle Scholar
  • 2b Prasit P. Wang Z. Brideau C. Chan C.-C. Charleson C. Cromlish W. Ethier D. Evans JF. Ford-Hutchinson AW. Gauthier JY. Gordon R. Guay J. Gresser M. Kargmann S. Kennedy B. Leblanc Y. Léger S. Mancini J. O’Neill GP. Ouellet M. Percival MD. Perrier H. Riendeau D. Rodger IW. Tagari P. Thérien M. Vickers P. Wong E. Xu L.-J. Young RN. Zamboni R. Bioorg. Med. Chem. Lett.  1999,  9:  1773 
    CrossrefGoogle Scholar
  • 3 Richardson C. Emery P. Drug Safety  1996,  15:  249 
    Google Scholar
  • 4 Forgione P. Wilson PD. Fallis AG. Tetrahedron Lett.  2000,  41:  17 
    CrossrefGoogle Scholar
  • 5 Cutler RA. Stenger RJ. Suter CM. J. Am. Chem. Soc.  1952,  74:  5475 
    CrossrefGoogle Scholar
  • 6 Ducharme Y, Gauthier JY, Prasit P, Leblanc Y, Wang Z, Léger S, and Thérien M. inventors; US Patent  .  5,474,995,